Back
Ionis Pharmaceuticals, Inc. (IONS)
BiotechnologyIONS · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$63.55
+2.40%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-2.38
ROE
-67.6%
Gross margin
10.9%
Debt/Equity
5.31x
Revenue growth
87.0%
Ionis Pharmaceuticals, Inc. — company intelligence
Earnings surprises
Q2 2026$-0.69 vs $-1.09 est+36.7%
Q1 2026$-0.56 vs $-0.93 est+39.7%
Q4 2025$-1.41 vs $-1.35 est-4.6%
Q3 2025$-0.80 vs $-1.26 est+36.4%
Analyst consensus · 31 analysts
25 Buy6 Hold0 Sell
Updated Aug 13, 2026
Insider activity · 90 days
20 buys7 sellsnet +13,130 shares
Hayden Michael RBuy 5,000 · Jul 31, 2026
Hayden Michael RBuy 15,000 · Jul 30, 2026
HERMAN JOAN Eother 5,220 · Jul 15, 2026
Recent SEC filings
4 — Insider transaction reportJul 31, 2026
8-K — Material event reportJul 29, 2026
10-Q — Quarterly reportJul 29, 2026
Latest news
This Sphere Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday — Benzinga · 5d ago
This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday — Benzinga · 6d ago
This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday — Benzinga · 6d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.